The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies.

[1]  P. Paggiaro,et al.  Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group. , 1996, The European respiratory journal.

[2]  A. Gulsvik,et al.  The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease. , 1994, Respiratory medicine.

[3]  J. Palmer,et al.  Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. , 1993, Thorax.

[4]  P. Rees,et al.  Theophylline. Current thoughts on the risks and benefits of its use in asthma. , 1993, Drug safety.

[5]  J. Muir,et al.  Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. French Multicentre Study Group. , 1992, The European respiratory journal.

[6]  J. Palmer,et al.  A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. , 1992, The European respiratory journal.

[7]  E. R. Mcfadden,et al.  Methylxanthines in the treatment of asthma: the rise, the fall, and the possible rise again. , 1991, Annals of internal medicine.

[8]  Neville Rg,et al.  Clinical audit of theophylline use in general practice. , 1991 .

[9]  I. D. Johnston.  Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications. , 1990, BMJ.

[10]  A. Ullman,et al.  Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. , 1988, Thorax.

[11]  S B Thacker,et al.  Meta-analysis. A quantitative approach to research integration. , 1988, JAMA.

[12]  C. Persson,et al.  Xanthines as airway anti-inflammatory drugs. , 1988, The Journal of allergy and clinical immunology.

[13]  A. Miller,et al.  Serum theophylline concentrations in general practice patients. , 1987, The Journal of the Royal College of General Practitioners.

[14]  D. Brown.  Serum theophylline concentration in general practice patients , 1987 .

[15]  J. Howard.  Audit of serum theophylline concentrations in patients from general practice. , 1987, The Journal of the Royal College of General Practitioners.

[16]  T. Chalmers,et al.  Meta-analyses of randomized controlled trials. , 1987, The New England journal of medicine.

[17]  S. Jackson,et al.  Prescribing Habits for Theophylline Preparations 1 , 1983, Journal of the Royal Society of Medicine.